Browsing by Author "Mansouri H"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    IKVAV-Containing Cell Membrane Penetrating Peptide Treatment Induces Changes in Cellular Morphology after Spinal Cord Injury
    (Canadian Center of Science and Education, 17/08/2016) Baltzer WI; kazemi S; Mansouri H; Mata J; Schilke K
    A cell membrane spanning peptide was used to increase the concentration of the IKVAV motif within damaged mouse spinal cord tissue. This peptide was injected directly to the lesion 24 hours after spinal cord compression injury. Because the membrane-spanning portion of the peptide adheres to tissue upon injection with a long half-life we hypothesized that the bioactive IKVAV sequence will provide a sustained regenerative signal at the sight of injury. Five different groups of mice were used and cellular morphology observations were undertaken using light and electron microscopy. Three surgical control groups: IKVAV, peptide and mannitol; one surgical treatment group: IKVAV-peptide; and one non-surgical control group: normal, were used in this experiment. In this study, treatment with IKVAV-peptide after SCI resulted in an increased number of protoplasmic astrocytes, large active motor neurons, and regeneration of muscle bundles followed by behavioral improvement. In this paper, we describe the cellular differences between all groups.
  • Thumbnail Image
    Item
    IKVAV-linked cell membrane-spanning peptide treatment induces neuronal reactivation following spinal cord injury
    (27/10/2015) Kazemi S; Baltzer WI; Schilke K; Mansouri H; Mata JE
    Spinal cord regeneration following treatment with a novel membrane-spanning peptide (MSP) expressing the isoleucine-lysine-valine-alanine-valine (IKVAV) epitope was assessed in Balb-c mice. After hemilaminectomy and compression injury, mice were treated with IKVAV, IKVAV-MSP, peptide or vehicle control. Functional improvement was assessed using modified Basso, Beattie, and Bresnahan Scale (mBBB) and spinal cord segments were studied histologically 28 days after injury. IKVAV-MSP group scores increased significantly compared with control groups after 4 weeks of observation (p < 0.05). The number of protoplasmic astrocytes, neurons and muscle bundle size in the IKVAV-MSP mice were significantly increased (p < 0.001; p < 0.05 and p < 0.007; respectively). This study demonstrates that it is possible to promote functional recovery after SCI using bioactive IKVAV presenting cell membrane-spanning peptides. Lay abstract: A new potential treatment for spinal cord injury was tested in mice. Mice were treated with our membrane-spanning peptide with the IKVAV motif (IKVAV-MSP) or various control treatments. Functional improvement was assessed daily and spinal cord segments were evaluated after 4 weeks. IKVAV-MSP treatment significantly restored function compared with control groups, numbers of health nerve cells within the spinal cord were increased and muscles appeared healthier. This study demonstrates that it is possible to promote functional recovery after SCI using bioactive IKVAV presenting cell membrane-spanning peptides.